IMMUNOLOGICAL MONITORING DURING RETREATMENT WITH OKT3

被引：0
|
作者：
FIRST, MR [1 ]
SCHROEDER, TJ [1 ]
HURTUBISE, PE [1 ]
MONSOUR, ME [1 ]
机构：
[1] UNIV CINCINNATI,MED CTR,CINCINNATI,OH 45267
来源：
KIDNEY INTERNATIONAL | 1989年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：514 / 514
页数：1
相关论文
共 50 条
  • [31] INVIVO USE OF OKT3 - MAIN ISSUES FOR THE MONITORING OF TREATED PATIENTS
    CHATENOUD, L
    FERRAN, C
    BACH, JF
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (06) : 2605 - 2608
  • [32] IMPLICATIONS OF MONITORING OKT3 THERAPY IN KIDNEY-GRAFTED PATIENTS
    ZLABINGER, GJ
    MAURER, D
    POHANKA, E
    ULRICH, W
    KOVARIK, J
    CLINICAL TRANSPLANTATION, 1990, 4 (05) : 257 - 264
  • [33] CEREBROSPINAL-FLUID INFLAMMATION DURING OKT3 THERAPY
    EMMONS, C
    SMITH, J
    FLANIGAN, M
    LANCET, 1986, 2 (8505): : 510 - 511
  • [34] CEREBROSPINAL-FLUID INFLAMMATION DURING OKT3 THERAPY
    RODEN, J
    KLINTMALM, GBG
    HUSBERG, BS
    NERY, J
    OLSON, LM
    LANCET, 1987, 2 (8553): : 272 - 272
  • [35] FINE NEEDLE ASPIRATION BIOPSY DURING AND AFTER OKT3
    JORGENSEN, KA
    STRATE, M
    SVENDSEN, V
    ROHR, N
    ELBIRK, A
    BIRKELAND, SA
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (04) : 3594 - 3595
  • [36] TREATMENT OF CYTOMEGALOVIRUS INFECTIONS WITH GANCYCLOVIR DURING OKT3 ADMINISTRATION
    HABERAL, M
    VELIDEDOGLU, E
    ARSLAN, G
    BILGIN, N
    BUYUKPAMUKCU, N
    KARAMEHMETOGLU, M
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (05) : 2707 - 2707
  • [37] Efficacy of rejection prophylaxis with OKT3
    Abramowicz, D
    Goldman, M
    TRANSPLANTATION, 1996, 62 (05) : 700 - 701
  • [38] PROPHYLACTIC OKT3 IN RENAL RETRANSPLANTATION
    CARDELLA, CJ
    BLAKE, P
    CATTRAN, D
    COLE, E
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (02) : 3373 - 3374
  • [39] EVIDENCE FOR GRANULOCYTE ACTIVATION BY OKT3
    SCHMALDIENST, S
    BOHMIG, G
    POHANKA, E
    KOVARIK, J
    ZLABINGER, GJ
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 2600 - 2601
  • [40] MECHANISMS OF ACTION AND OVERVIEW OF OKT3
    NORMAN, DJ
    THERAPEUTIC DRUG MONITORING, 1995, 17 (06) : 615 - 620
12345